Discovery of the Factor Xa Inhibitor, ZK 807834 (CI-1031)

E-ISSN： 1873-4294|1|2|121-136

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.1, Iss.2, 2001-06, pp. : 121-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis

By McClanahan T.B. Hicks G.W. Morrison A.L. Peng Y.-W. Janiczek-Dolphin N. Mertz T.E. Sullivan M.E. Morser J. Juneau P.L. Leadley R.

European Journal of Pharmacology, Vol. 432, Iss. 2, 2001-12 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identification to Clinical Development

Current Medicinal Chemistry, Vol. 14, Iss. 23, 2007-10 ,pp. : 2471-2481

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the discovery of Factor Xa inhibitors

By Casimiro-Garcia Agustin Dudley Danette A Heemstra Ronald J Filipski Kevin J Bigge Christopher F Edmunds Jeremy J

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 119-145

Informa Healthcare

Access to resources Recommend Favorite

Edoxaban: A New Oral Direct Factor Xa Inhibitor

By Camm A. John

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1503-1526

Adis International

Access to resources Recommend Favorite

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy

By Turpie Alexander GG

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1373-1384

Informa Healthcare

Access to resources Recommend Favorite